ATE381576T1 - Verfahren zur aufreinigung eines n-terminalen fragments des hepatozytenwachstumsfaktors - Google Patents

Verfahren zur aufreinigung eines n-terminalen fragments des hepatozytenwachstumsfaktors

Info

Publication number
ATE381576T1
ATE381576T1 AT05707681T AT05707681T ATE381576T1 AT E381576 T1 ATE381576 T1 AT E381576T1 AT 05707681 T AT05707681 T AT 05707681T AT 05707681 T AT05707681 T AT 05707681T AT E381576 T1 ATE381576 T1 AT E381576T1
Authority
AT
Austria
Prior art keywords
growth factor
hepatocyte growth
purifying
terminal fragment
naturation
Prior art date
Application number
AT05707681T
Other languages
English (en)
Inventor
Friederike Hesse
Martin Lanzendoerfer
Apollon Papadimitriou
Jan Stracke
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE381576T1 publication Critical patent/ATE381576T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05707681T 2004-03-03 2005-03-02 Verfahren zur aufreinigung eines n-terminalen fragments des hepatozytenwachstumsfaktors ATE381576T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04004950 2004-03-03

Publications (1)

Publication Number Publication Date
ATE381576T1 true ATE381576T1 (de) 2008-01-15

Family

ID=34924467

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05707681T ATE381576T1 (de) 2004-03-03 2005-03-02 Verfahren zur aufreinigung eines n-terminalen fragments des hepatozytenwachstumsfaktors

Country Status (9)

Country Link
US (1) US7544493B2 (de)
EP (1) EP1723171B1 (de)
JP (2) JP4511589B2 (de)
CN (1) CN1926150B (de)
AT (1) ATE381576T1 (de)
CA (1) CA2558740A1 (de)
DE (1) DE602005003929T2 (de)
ES (1) ES2297673T3 (de)
WO (1) WO2005095449A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2020158690A1 (ja) * 2019-01-28 2021-12-16 東レ株式会社 肝細胞増殖因子又はその活性断片のポリエチレングリコール修飾体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE222603T1 (de) 1992-05-18 2002-09-15 Genentech Inc Hepatozytwachstumfaktor variante
EP0816381B1 (de) 1995-03-10 2004-01-14 NAKAMURA, Toshikazu Menschlicher wachstumsfaktor (hgf), verändert durch polyethylenglykol
US6855685B2 (en) * 1995-10-24 2005-02-15 Toshikazu Nakamura Anti-cancer agent
AUPO156596A0 (en) * 1996-08-09 1996-09-05 University Of Sydney, The Synthetic polynucleotides
EP1958962A3 (de) * 1997-06-12 2013-05-01 Novartis International Pharmaceutical Ltd. Künstliche Antikörperpolypeptide
EP1234583A1 (de) 2001-02-23 2002-08-28 F. Hoffmann-La Roche Ag PEG-Konjugate des HGF-NK4
US20040052777A1 (en) * 2002-09-04 2004-03-18 Mark Nesbit Kringle polypeptides and methods for using them to inhibit angiogenesis

Also Published As

Publication number Publication date
CN1926150B (zh) 2010-04-14
US20070287827A1 (en) 2007-12-13
EP1723171A1 (de) 2006-11-22
ES2297673T3 (es) 2008-05-01
DE602005003929D1 (de) 2008-01-31
WO2005095449A1 (en) 2005-10-13
US7544493B2 (en) 2009-06-09
CA2558740A1 (en) 2005-10-13
JP2007525219A (ja) 2007-09-06
CN1926150A (zh) 2007-03-07
DE602005003929T2 (de) 2008-12-04
EP1723171B1 (de) 2007-12-19
JP2010119393A (ja) 2010-06-03
JP4511589B2 (ja) 2010-07-28

Similar Documents

Publication Publication Date Title
DK1422237T3 (da) Fremgangsmåder til rekombinant frembringelse af antifusogene peptider
BR122019022434B8 (pt) método para cultivar células de mamífero que secretam proteína heteróloga em um sobrenadante de cultura celular
ATE421994T1 (de) Genexpressionsmethode
SG162834A1 (en) Refolding of recombinant proteins
MX2010004325A (es) Secuencias de señal y chaperones co-expresados para mejorar produccion de proteinas en una celula hospedera.
DE602006018587D1 (de) Verfahren zur verbesserten isolierung rekombinant produzierter proteine
PE20090731A1 (es) Metodos de produccion de proteinas basados en medios de cultivos celulares que comprenden compuestos anti-senescencia
ATE374828T1 (de) Expressionsvektor zur antibiotikafreien expression
MY149949A (en) Apparatus comprising a circular buffer and method for assigning redundancy versions to a circular buffer
MY185040A (en) Cell culture improvements
GB2446525A (en) Stem cell culture medium and method
UA103176C2 (ru) Растение с повышенными показателями урожайности и способ его получения
WO2008024769A3 (en) Intensified perfusion production method
UA92157C2 (ru) Способ продуцирования гормона роста
NZ593239A (en) Fusion Collagenase in which affinity TAG is linked and method for producing the same
WO2007130535A3 (en) Novel protein fusion/tag technology
GB0208041D0 (en) Method of culturing animal cells
WO2006128764A3 (en) Process for cultivating animal cells comprising the feeding of plant-derived peptones
DE602004025011D1 (de) Verfahren zur herstellung rekombinanter proteine
ATE469917T2 (de) Verfahren zur gewinnung von antikörpern
ATE349513T1 (de) Verfahren zur homogenen masskultivierung von t- lymphozyten
EA201000945A1 (ru) Конструирование системы секреции на основе sm-белков
TW200801197A (en) Methods for production of dioic acids
EA200900984A1 (ru) Улучшение клеточного роста
ATE513921T1 (de) Verfahren zur herstellung reifer insulinpolypeptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties